These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 30476307

  • 1. International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity Testing.
    Sachana M, Bal-Price A, Crofton KM, Bennekou SH, Shafer TJ, Behl M, Terron A.
    Toxicol Sci; 2019 Jan 01; 167(1):45-57. PubMed ID: 30476307
    [Abstract] [Full Text] [Related]

  • 2. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
    Sachana M, Willett C, Pistollato F, Bal-Price A.
    Reprod Toxicol; 2021 Aug 01; 103():159-170. PubMed ID: 34147625
    [Abstract] [Full Text] [Related]

  • 3. Toward a Better Testing Paradigm for Developmental Neurotoxicity: OECD Efforts and Regulatory Considerations.
    Sachana M, Shafer TJ, Terron A.
    Biology (Basel); 2021 Jan 23; 10(2):. PubMed ID: 33498772
    [Abstract] [Full Text] [Related]

  • 4. Towards a regulatory use of alternative developmental neurotoxicity testing (DNT).
    Terron A, Bennekou SH.
    Toxicol Appl Pharmacol; 2018 Sep 01; 354():19-23. PubMed ID: 29454059
    [Abstract] [Full Text] [Related]

  • 5. OECD/EFSA workshop on developmental neurotoxicity (DNT): The use of non-animal test methods for regulatory purposes.
    Fritsche E, Crofton KM, Hernandez AF, Hougaard Bennekou S, Leist M, Bal-Price A, Reaves E, Wilks MF, Terron A, Solecki R, Sachana M, Gourmelon A.
    ALTEX; 2017 Sep 01; 34(2):311-315. PubMed ID: 28407175
    [No Abstract] [Full Text] [Related]

  • 6. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
    Fritsche E, Grandjean P, Crofton KM, Aschner M, Goldberg A, Heinonen T, Hessel EVS, Hogberg HT, Bennekou SH, Lein PJ, Leist M, Mundy WR, Paparella M, Piersma AH, Sachana M, Schmuck G, Solecki R, Terron A, Monnet-Tschudi F, Wilks MF, Witters H, Zurich MG, Bal-Price A.
    Toxicol Appl Pharmacol; 2018 Sep 01; 354():3-6. PubMed ID: 29447839
    [Abstract] [Full Text] [Related]

  • 7. Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.
    Bal-Price A, Hogberg HT, Crofton KM, Daneshian M, FitzGerald RE, Fritsche E, Heinonen T, Hougaard Bennekou S, Klima S, Piersma AH, Sachana M, Shafer TJ, Terron A, Monnet-Tschudi F, Viviani B, Waldmann T, Westerink RHS, Wilks MF, Witters H, Zurich MG, Leist M.
    ALTEX; 2018 Sep 01; 35(3):306-352. PubMed ID: 29485663
    [Abstract] [Full Text] [Related]

  • 8. Recommendations for harmonization of data collection and analysis of developmental neurotoxicity endpoints in regulatory guideline studies: Proceedings of workshops presented at Society of Toxicology and joint Teratology Society and Neurobehavioral Teratology Society meetings.
    Li AA, Sheets LP, Raffaele K, Moser V, Hofstra A, Hoberman A, Makris SL, Garman R, Bolon B, Kaufmann W, Auer R, Lau E, Vidmar T, Bowers WJ.
    Neurotoxicol Teratol; 2017 Sep 01; 63():24-45. PubMed ID: 28757310
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Meeting report: alternatives for developmental neurotoxicity testing.
    Lein P, Locke P, Goldberg A.
    Environ Health Perspect; 2007 May 01; 115(5):764-8. PubMed ID: 17520065
    [Abstract] [Full Text] [Related]

  • 12. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
    Bal-Price A, Pistollato F, Sachana M, Bopp SK, Munn S, Worth A.
    Toxicol Appl Pharmacol; 2018 Sep 01; 354():7-18. PubMed ID: 29476865
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Zebrafish and nematodes as whole organism models to measure developmental neurotoxicity.
    Hughes S, Hessel EVS.
    Crit Rev Toxicol; 2024 May 01; 54(5):330-343. PubMed ID: 38832580
    [Abstract] [Full Text] [Related]

  • 16. Screening for Developmental Neurotoxicity at the National Toxicology Program: The Future Is Here.
    Behl M, Ryan K, Hsieh JH, Parham F, Shapiro AJ, Collins BJ, Sipes NS, Birnbaum LS, Bucher JR, Foster PMD, Walker NJ, Paules RS, Tice RR.
    Toxicol Sci; 2019 Jan 01; 167(1):6-14. PubMed ID: 30496580
    [Abstract] [Full Text] [Related]

  • 17. Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.
    Aschner M, Ceccatelli S, Daneshian M, Fritsche E, Hasiwa N, Hartung T, Hogberg HT, Leist M, Li A, Mundi WR, Padilla S, Piersma AH, Bal-Price A, Seiler A, Westerink RH, Zimmer B, Lein PJ.
    ALTEX; 2017 Jan 01; 34(1):49-74. PubMed ID: 27452664
    [Abstract] [Full Text] [Related]

  • 18. International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes.
    Bal-Price A, Crofton KM, Leist M, Allen S, Arand M, Buetler T, Delrue N, FitzGerald RE, Hartung T, Heinonen T, Hogberg H, Bennekou SH, Lichtensteiger W, Oggier D, Paparella M, Axelstad M, Piersma A, Rached E, Schilter B, Schmuck G, Stoppini L, Tongiorgi E, Tiramani M, Monnet-Tschudi F, Wilks MF, Ylikomi T, Fritsche E.
    Arch Toxicol; 2015 Feb 01; 89(2):269-87. PubMed ID: 25618548
    [Abstract] [Full Text] [Related]

  • 19. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
    Crofton KM, Mundy WR, Lein PJ, Bal-Price A, Coecke S, Seiler AE, Knaut H, Buzanska L, Goldberg A.
    ALTEX; 2011 Feb 01; 28(1):9-15. PubMed ID: 21311847
    [Abstract] [Full Text] [Related]

  • 20. Recent advances and current challenges of new approach methodologies in developmental and adult neurotoxicity testing.
    Serafini MM, Sepehri S, Midali M, Stinckens M, Biesiekierska M, Wolniakowska A, Gatzios A, Rundén-Pran E, Reszka E, Marinovich M, Vanhaecke T, Roszak J, Viviani B, SenGupta T.
    Arch Toxicol; 2024 May 01; 98(5):1271-1295. PubMed ID: 38480536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.